Skip to content

Debt-to-assets at other companies

Abbott logo
AbbottABT
0.3×+0.1×
Johnson & Johnson logo
Johnson & JohnsonJNJ
0.3×0.0×
Boston Scientific logo
Boston ScientificBSX
-0.3×
Medtronic logo
MedtronicMDT
0.3×0.0×
Merit Medical Systems logo
Merit Medical SystemsMMSI
0.3×0.0×
ITG
Integer HoldingsITGR
0.4×0.0×

Other financials

Income statement

See full
Revenue$401.0K
Gross profit$31.0K
Operating income-$19.2M-6.1%
Net income-$18.6M-10.6%
EPS (diluted)-$0.49-2.1%

Balance sheet

See full
Cash & equivalents$68.3M-42.7%
Total debt$7.2M-16.6%
Total equity$66.3M-44.0%
Total assets$81.6M-38.8%

Cash flow

See full
Operating cash flow-$14.6M-7.9%
CapEx$33.0K-26.7%
Free cash flow-$14.6M-7.8%

Valuation

See full
Market cap$1.77B+38.4%

Profitability

See full
Gross margin-4,067.5%
Operating margin-10,392.1%
Net margin-9,929%
FCF margin-7,390%

Returns & leverage

See full
Return on equity-80.7%+3.1pp
Debt / equity0.1×0.0×
Current ratio7.3×-8.3×

Where this comes from

Calculated from Pulse Biosciences, Inc.’s reported figures.

Based on the most recent quarter.

The official record: Pulse Biosciences, Inc.’s 10-Q, filed May 14, 2026, on SEC EDGAR. View the filing →

Ask your AI about Pulse Biosciences, Inc.'s debt-to-assets.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Pulse Biosciences, Inc.'s debt-to-assets?
Pulse Biosciences, Inc. (PLSE) reported debt-to-assets of 0.1× in Q1 2026.
How has Pulse Biosciences, Inc.'s debt-to-assets changed year-over-year?
Pulse Biosciences, Inc.'s debt-to-assets increased by 36.4% year-over-year, from 0.1× to 0.1×.
What is the long-term trend for Pulse Biosciences, Inc.'s debt-to-assets?
Over 5 years (2020 to 2025), Pulse Biosciences, Inc.'s debt-to-assets has grown at a -22.0% compound annual growth rate (CAGR), from 0.3× to 0.1×.
What does debt-to-assets mean?
Total debt divided by total assets at the quarter end. Measures the share of the asset base financed by debt.